Milton H. Werner - 03 Jan 2022 Form 4 Insider Report for Inhibikase Therapeutics, Inc. (IKT)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Milton H. Werner
Issuer symbol
IKT
Transactions as of
03 Jan 2022
Net transactions value
+$44,143
Form type
4
Filing time
04 Jan 2022, 20:25:42 UTC
Previous filing
19 Nov 2021
Next filing
09 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IKT Common Stock Options Exercise $44,143 +21,853 +0.41% $2.02 5,315,433 03 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKT Stock Option (right to buy) Options Exercise $0 -21,853 -100% $0.000000* 0 03 Jan 2022 Common Stock 21,853 $2.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested in twelve equal monthly installments beginning on March 1, 2015.